Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Nanotechnology Platform Shows Promise for Treating Pancreatic Cancer

March 24, 2015 12:48 pm | by UCLA | News | Comments

Scientists at UCLA’s California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer. Read more...


Pfizer, Lilly To Resume Phase 3 Chronic Pain Program For Tanezumab

March 24, 2015 12:37 pm | News | Comments

Pfizer Inc. and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical program for tanezumab. Read more...


Bristol-Myers Acquires Novo License for Autoimmune Diseases Research Program

March 24, 2015 12:33 pm | News | Comments

Bristol-Myers Squibb Company announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases. Read more...


Enzyme that Helps Prevent Anemia: Discovery

March 24, 2015 12:19 pm | by Scripps Research Institute | News | Comments

​Stem cells can generate any type of cell in the body, but they are inactive most of the time—and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations. Read more...


Gilead Issues Safety Alert over Hepatitis C, Heart Drug Combination

March 24, 2015 12:03 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Taking these medications together is ill-advised.


Cipher Pharmaceuticals Acquires Canadian Rights to Novel Psoriasis, Rheumatoid Arthritis Treatment

March 24, 2015 8:54 am | News | Comments

Approximately 500,000 in Canada people receive treatment for psoriasis. Read more...


Blood Thinning Drug Aids Understanding of Natural HIV Barrier

March 24, 2015 8:50 am | by University of East Anglia | News | Comments

A blood thinning agent is helping researchers understand more about the body’s natural barriers to HIV. Read more...


Scientists Use DNA Sequencing to Trace Spread of Drug Resistant TB

March 24, 2015 8:45 am | by Sam Wong, Imperial College London | News | Comments

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK. Read more...


WHO Denies Politics Swayed Ebola Emergency Declaration

March 24, 2015 8:40 am | by Maria Cheng and Raphael Satter, Associated Press | News | Comments

The World Health Organization denied Monday that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year. Read more...


Neovacs Launches American Subsidiary in Boston

March 24, 2015 8:36 am | News | Comments

Neovacs will be located in Boston within the French Tech Hub. Read more...


Mutated Gene Increases Insulin Resistance

March 24, 2015 8:31 am | by Becky Bach, Stanford University | News | Comments

An international team of researchers at the Stanford has discovered a gene that, when mutated, increases insulin resistance. Read more...


Blood Test for Patients on Acne Medication Deemed Unnecessary

March 23, 2015 10:58 am | by Brigham and Women's Hospital | News | Comments

A new study by researchers at Brigham and Women's Hospital (BWH) has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense. Read more...


Potential Drug Target for Protection against Neurodegenerative Diseases

March 23, 2015 10:39 am | by UPenn | News | Comments

Penn Medicine researchers have discovered that hypermethylation - the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD) - serves as a protective barrier inhibiting the development of these diseases. Read more...

Scientists Win $1.5 Million Grant to Develop New Cancer Drugs

March 23, 2015 10:14 am | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $1.5 million grant from the National Institutes of Health (NIH) to develop drug candidates that could treat cancer and neurodegenerative disease. Read more..


Small Cellular Changes Research May Lead to Cancer Solutions

March 23, 2015 10:05 am | by University of Colorado | News | Comments

Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. Read more...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.